Related Experiment Video
Updated: Jun 25, 2026
05:05
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
Published on: June 17, 2025
Anti-laminin gamma-1 pemphigoid
Teruki Dainichi1, Sadamu Kurono, Bungo Ohyama
1Department of Dermatology, Kurume University School of Medicine, Fukuoka 830-0011, Japan.
Summary
Researchers identified laminin gamma1 as the target autoantigen in anti-p200 pemphigoid. Autoantibodies in patients with this autoimmune blistering disease specifically recognize dermal laminin gamma1.
Area of Science:
- Immunodermatology
- Autoimmunity
- Protein identification
Background:
- Anti-p200 pemphigoid is an autoimmune blistering disease.
- Characterized by autoantibodies against an unknown 200-kDa protein (p200) at the dermal-epidermal junction.
Purpose of the Study:
- To identify the specific protein targeted by autoantibodies in anti-p200 pemphigoid.
Main Methods:
- 2D gel electrophoresis of dermal extracts.
- Immunoblotting with patient sera.
- Mass spectrometry (MS) analysis.
- Recombinant protein expression and antibody assays.
Main Results:
- The p200 protein was identified as laminin gamma1.
- Sera from 90% of anti-p200 pemphigoid patients reacted with recombinant laminin gamma1.
- Autoantibody reactivity was specific to dermal laminin gamma1, particularly the C-terminal E8 fragment.
Conclusions:
- Laminin gamma1 is the autoantigen in anti-p200 pemphigoid.
- Autoantibodies likely target unique post-translational modifications of dermal laminin gamma1.
- The epitope is localized to the C-terminal coiled-coil domain.
